Name

GCP

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for GCP

Name

Alternate Names

Gemcitabine Hydrochloride
Gemzar
LY 188011
LY-188011
LY188011 hydrochloride
Gemcitabine HCL

Abbreviations

None

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

613327

Primary Site

Bladder
Breast
non-small cell lung
ovarian
pancreatic cancer
Soft Tissue Sarcoma

Histology

None

Remarks

FDA approved for breast. ovarian, pancreas, NSC lung
Gemcitabine HCL is given intravesically as treatment for bladder tumors. Code as chemotherapy.

Coding

This drug should be coded

Name

Alternate Names

BMS-181339-01
BMY-45622
Taxol

Abbreviations

None

Category

Chemotherapy

Subcategory

Mitotic inhibitor
plant alkaloid
Taxane

NSC Number

125973
673089

Primary Site

breast
Gastric
head & neck cancer
Kaposi's sarcoma
non-small cell lung cancers
ovarian

Histology

None

Remarks

Phase I (gastric) FDA approved uses on breast, ovarian, non-small cell lung cancers, and Kaposi's sarcoma. Bristol-Myers Squibb.

Coding

This drug should be coded

Name

Alternate Names

JM 8
JM-8
JM8
Paraplatin

Abbreviations

CBDCA

Category

Chemotherapy

Subcategory

Alkylating agent
Platinum analog

NSC Number

241240

Primary Site

All cancers

Histology

None

Remarks

A platinum-salt alkylating agent.

Coding

This drug should be coded
Glossary